The Canadian firm will be announcing a menu for the Spartan Cube at August's American Association of Clinical Chemistry conference and will seek CLIA waiver.
Richard Wilson and Elaine Mardis plan to use comprehensive sequencing to transition genomic discoveries into clinical assays for pediatric cancer and germline disorders.
Through the deal, the partners will offer tailored genomic guidance on nutrition, fitness, skin care, and other wellness topics to customers.
The firm has taken full ownership of its CLIA-certified joint venture laboratory in a bid to bail it out, and is raising money to continue operations.
The companies will combine Qiagen's QIAxcel and CareDx's Olerup SSP kits and Score software into an HLA typing product offering for transplant labs.
In PNAS this week: peanut subgenome progenitor sequence, homozygosity mapping and linkage analyses using exome data, and more.
Tech companies like Microsoft are looking into DNA as a data storage device, Scientific American writes.
The New York Times writes that the Max Planck Institute for Infection Biology's Emmanuelle Charpentier has always been on the move, though now it's more about CRISPR.
The European Union calls for all publicly funded scientific papers to be immediately freely accessible to the public by 2020.